The Clinical Significance of the CD44v6 Expression in Peripheral Blood Mononuclear Cell and Cancerous Tissue of Patients with Gastric Cancer

JI Feng,ZHENG Shu-bei,LU Pei-lin,CUI Jun-hui,YU Ji-ren,LI You-ming

DOI: https://doi.org/10.3760/j:issn:1009-9158.2005.04.021

2005-01-01

Abstract:Objective To investigate the clinical significance of cell surface differentiation antigen 44 (CD44) expression that shared spliced variant 6 (CD44v6)in peripheral blood mononuclear cell(PBMC)and cancerous tissue of patients with gastric carcinoma.Methods Flow cytometry was used to analyze the CD44v6 expression in the primary tumor tissue and these corresponding paracancer normal tissue after gastrectomy and in PBMC at pre-operation and post-operation one week later in 50 patients with gastric cancer and 20 normal controls.Results CD44v6 expression in PBMC was significantly higher in pre-operation of gastric cancer (9.72%±6.65%) than that in both normal controls(3.11%±1.15%) and post-operation one week later (4.44%±2.33%,P0.001 and P0.01 respectively). The significant increase (P0.01) of CD44v6 expression was found in cancerous tissue (3.67%±0.63%) when compared with corresponding paracancer normal tissue of gastric cancer(1.33%±0.51%). The level of CD44v6 expressions in PBMC and cancerous tissue in patients with gastric cancer of Ⅲ ± Ⅳ stage(12.56%±6.97% and 3.91%±0.87% respectively) was significantly higher than that of Ⅰ ±Ⅱ stage(6.89%±3.37% and 2.86%±0.65% respectively,both P0.05). CD44v6 expressions in PBMC and cancerous tissue in patients with lymph node metastasis (11.29%±5.36% and 4.41%±0.79% respectively)were significantly higher than that of patients without lymph node metastasis(7.32%±4.28% and 2.61%±0.78% respectively,both P0.05).Conclusions The level of CD44v6 expression in PBMC may be a marker of monitoring the changes of CD44v6 in gastric cancerous tissue and of important clinical value in the diagnosis,judgment of tumor development and metastasis and therapeutic evaluation for the patients with gastric cancer by flow cytometry.